Overdiagnosis and Overtreatment of Prostate Cancer - Estadísticas de Google Académico

Artículos que citan Overdiagnosis and Overtreatment of Prostate Cancer

Título / Autor	Año
Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ... European urology 68 (6), 1045-1053	2015
Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453	2016
Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound–guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies MR Pokorny, M De Rooij, E Duncan, FH Schröder, R Parkinson, ... European urology 66 (1), 22-29	2014
Annual report to the nation on the status of cancer, 1975–2014, featuring survival A Jemal, EM Ward, CJ Johnson, KA Cronin, J Ma, AB Ryerson, A Mariotto, ... JNCI: Journal of the National Cancer Institute 109 (9), djx030	2017
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference HA Vargas, AM Hötker, DA Goldman, CS Moskowitz, T Gondo, ... European radiology 26 (6), 1606-1612	2016
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study H Grönberg, J Adolfsson, M Aly, T Nordström, P Wiklund, Y Brandberg, ... The lancet oncology 16 (16), 1667-1676	2015
The changing incidence of thyroid cancer CM Kitahara, JA Sosa Nature Reviews Endocrinology 12 (11), 646	2016
The prostate health index selectively identifies clinically significant prostate cancer S Loeb, MG Sanda, DL Broyles, SS Shin, CH Bangma, JT Wei, AW Partin, ... The Journal of urology 193 (4), 1163-1169	2015
Active surveillance for prostate cancer: current evidence and contemporary state of practice JJ Tosoian, HB Carter, A Lepor, S Loeb Nature Reviews Urology 13 (4), 205	2016
Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations JD Sammon, F Abdollah, TK Choueiri, PW Kantoff, PL Nguyen, M Menon, ... Jama 314 (19), 2077-2079	2015
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer P Blume-Jensen, DM Berman, DL Rimm, M Shipitsin, M Putzi, TP Nifong, ... Clinical cancer research 21 (11), 2591-2600	2015
Effect of the USPSTF grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the United States DA Barocas, K Mallin, AJ Graves, DF Penson, B Palis, DP Winchester, ... The Journal of urology 194 (6), 1587-1593	2015
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error M Shipitsin, C Small, S Choudhury, E Giladi, S Friedlander, J Nardone, ... British journal of cancer 111 (6), 1201	2014
The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era JL Jahn, EL Giovannucci, MJ Stampfer International journal of cancer 137 (12), 2795-2802	2015
Assessment of PI-RADS v2 for the detection of prostate cancer M Kasel-Seibert, T Lehmann, R Aschenbach, FV Guettler, M Abubrig, ... European journal of radiology 85 (4), 726-731	2016
Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial RM Martin, JL Donovan, EL Turner, C Metcalfe, GJ Young, EI Walsh, ... Jama 319 (9), 883-895	2018
Cancer epidemiology and prevention M Thun, MS Linet, JR Cerhan, CA Haiman, D Schottenfeld Oxford University Press	2017
New technologies for analysis of extracellular vesicles H Shao, H Im, CM Castro, X Breakefield, R Weissleder, H Lee Chemical reviews 118 (4), 1917-1950	2018
Preoperative prostate-specific antigen isoform p2PSA and its derivatives,% p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer: results from a multicentric European prospective study N Fossati, NM Buffi, A Haese, C Stephan, A Larcher, T McNicholas, ... European urology 68 (1), 132-138	2015
Gleason 6 prostate cancer: translating biology into population health SE Eggener, K Badani, DA Barocas, GW Barrisford, JS Cheng, AI Chin, ... The Journal of urology 194 (3), 626-634	2015

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.